|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Cash flows used in operating activities | ||||
| Net Loss | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Stock-based compensation expense | ||||
| Non-cash operating lease expense | ||||
| Net accretion of discount on investments | ||||
| Changes in operating assets and liabilities: | ||||
| Prepaid expenses and other assets | ||||
| Accounts payable | ||||
| Accrued compensation | ||||
| Accrued liabilities | ||||
| Operating lease liabilities | ||||
| Other current liabilities | ||||
| Other non-current liabilities | ||||
| Net cash used in operating activities | ||||
| Cash flows from investing activities | ||||
| Purchases of investments | ||||
| Maturities of investments | ||||
| Net cash provided by investing activities | ||||
| Cash flows from financing activities | ||||
| Proceeds from issuance of common stock from the Underwritten Offering, net of commissions and offering expenses | ||||
| Proceeds from issuance of common stock from the "at-the-market" offering, net of commissions and offering expenses | ||||
| Proceeds from issuance of common stock under the ESPP | ||||
| Proceeds from exercise of stock options | ||||
| Net cash provided by financing activities | ||||
| Net (decrease) increase in cash and cash equivalents | ||||
| Cash and cash equivalents at the beginning of the period | ||||
| Cash and cash equivalents at the end of the period | ||||
Loading...